Business / Finance

RSS

Johns Hopkins cardiologist receives first Harrington prize for innovation in medicine

Johns Hopkins pediatric cardiologist and geneticist Hal Dietz, M.D., has been awarded the first Harrington Prize for Innovation in Medicine for his work identifying the cause and a treatment for Marfan syndrome.

13 Feb 2014

ALK announces acquisition of Bio-Medical Services

ALK, the world's leading allergen extract manufacturer, announces the acquisition of Bio-Medical Services, a veterinary reference laboratory who pioneered in vitro serum IgE allergy testing in the veterinary industry.

12 Feb 2014

Horizon Discovery, Haplogen sign worldwide distribution agreement

Horizon Discovery, a leading provider of research tools to support translational genomics and the development of personalized medicines, today announced it has signed a worldwide distribution agreement with Haplogen GmbH, with immediate effect.

12 Feb 2014

Natera initiates distribution partnership with ProPath for Panorama non-invasive prenatal screening test

Natera, a leading innovator in prenatal genetic testing, today announced the initiation of a distribution partnership with ProPath, a wholly physician-owned provider of pathology services to clinicians and medical facilities in the United States, for its Panorama non-invasive prenatal screening test (NIPT).

From Natera 12 Feb 2014

Intelligent Hospital Systems, Nevo Medical sign distribution agreement

Intelligent Hospital Systems, maker of the RIVA fully-automated IV compounding system, today announced a distribution agreement with Tel Aviv-based Nevo Medical Ltd. The healthcare and medical equipment supplier will serve as IH Systems' exclusive distributor in Israel and the Palestine Authority, further increasing the reach of RIVA systems globally.

12 Feb 2014

QualMetrix closes oversubscribed Series A financing round

QualMetrix, Inc., a healthcare analytics company delivering actionable insights to payers, providers, pharma and employers to help them reduce cost while enhancing the quality of healthcare, announced the close of an oversubscribed Series A financing round.

12 Feb 2014

Scientists receive €85 million international drive to develop new and effective drugs

An increasing biological resistance to antibiotics treatment is to be countered by Aston University scientists who will lead a €85 million international drive to develop new and effective drugs.

12 Feb 2014

PAREXEL launches marketing initiative to simplify journey from science to new treatments

As the global biopharmaceutical industry increasingly seeks to streamline the complex process of bringing new drugs to market, PAREXEL International Corporation, a leading global biopharmaceutical services provider, today announced the launch of a new marketing initiative that highlights the Company's proven approach to help clients simplify the journey from science to new treatments.

From Parexel 12 Feb 2014

DCR enters into agreement with Pyxant Labs for early clinical trials

DaVita Clinical Research, a specialty contract research organization with services spanning the full spectrum of drug and device development, announced today that it has entered into an agreement through which Pyxant Labs Inc. will provide bioanalytical laboratory services for DCR's early clinical trials.

12 Feb 2014

ADM commits $25 million equity investment in Rennovia

Archer Daniels Midland Company and Rennovia, Inc. announced today that ADM has committed to a $25 million equity investment in the privately held company, which develops catalysts and processes for the cost-advantaged production of chemical products from renewable feedstocks.

11 Feb 2014

QuadraMed strikes strategic partnership with Connected Technology Solutions

QuadraMed Corporation is pleased to announce that it has signed an agreement with Connected Technology Solutions, a leading interactive kiosk design and creative marketing company. As part of the agreement, QuadraMed's intuitive point-of-service patient registration solution, QuadraMed MediKiosk, will run on CTS kiosk technology, offering organizations a proven, cost-effective patient registration and check-in solution.

11 Feb 2014

Theorem Clinical Research forms strategic alliance with Decision Driver Analytics

Theorem Clinical Research has announced the formation of a strategic alliance with Decision Driver Analytics that will integrate health economics and outcomes research (HEOR), predictive modeling and definitive analysis to maximize return on investment for pharmaceutical and medical device research programs.

11 Feb 2014

Ligand Pharmaceuticals' total revenues for Q4 2013 increase 8% to $14.7 million

Ligand Pharmaceuticals Incorporated today reported financial results for the three and 12 months ended December 31, 2013, and provided an operating forecast and program updates.

11 Feb 2014

Zoetis reports revenue of $1.25 billion for Q4 2013

Zoetis Inc. today reported its financial results for the fourth quarter and full year 2013. The company reported revenue of $1.25 billion for the fourth quarter of 2013, an increase of 7% from the fourth quarter of 2012. Revenue reflected an operational increase of 9%, with foreign currency having a negative impact of 2 percentage points.

11 Feb 2014

Mallinckrodt's subsidiary to acquire all outstanding shares of Cadence Pharmaceuticals

Mallinckrodt plc, a leading global specialty pharmaceuticals company, and Cadence Pharmaceuticals, Inc. today announced that they have entered into a definitive agreement under which a subsidiary of Mallinckrodt plc will commence a tender offer to acquire all outstanding shares of Cadence Pharmaceuticals, Inc. for $14.00 per share in cash or approximately $1.3 billion on a fully diluted basis, which represents a 32% premium to the trailing 30-trading-day volume weighted average price (VWAP) of $10.62 per share for Cadence Pharmaceuticals, Inc.

11 Feb 2014

Cambrex fourth quarter sales increase 46.3% to $103 million

Cambrex Corporation reports results for the fourth quarter and full year ended December 31, 2013.

11 Feb 2014

Cardiome Pharma's subsidiary signs agreement with Tamro to distribute BRINAVESS in Sweden

Cardiome Pharma Corp. today announced that its subsidiary, Correvio GmbH, has entered into an agreement with Tamro AB, headquartered in Gothenburg, Sweden, to distribute BRINAVESS (vernakalant IV) to customers in the Swedish market.

11 Feb 2014

Henry Schein net sales increase 4.9% to $2.5 billion in fourth quarter 2013

Henry Schein, Inc., the world's largest provider of health care products and services to office-based dental, animal health and medical practitioners, today reported record financial results for the quarter ended December 28, 2013.

11 Feb 2014

UPS completes acquisition of U.K.-based Polar Speed

UPS today announced it has completed the purchase of U.K.-based Polar Speed, an innovative provider of temperature-sensitive pharmaceutical supply chain solutions in the U.K. The acquisition further strengthens UPS's healthcare network across Europe, providing healthcare companies access to a single source for logistics solutions across the continent.

11 Feb 2014

GenomOncology collaborates with RPCI to develop informatics solution for Next Generation Sequencing

GenomOncology today announced a collaboration with Roswell Park Cancer Institute (RPCI) to develop an informatics solution that enables the association of Next Generation Sequencing results with knowledge resources to define actionable mutations.

11 Feb 2014

Business / Finance

Johns Hopkins cardiologist receives first Harrington prize for innovation in medicine

ALK announces acquisition of Bio-Medical Services

Horizon Discovery, Haplogen sign worldwide distribution agreement

Natera initiates distribution partnership with ProPath for Panorama non-invasive prenatal screening test

Intelligent Hospital Systems, Nevo Medical sign distribution agreement

QualMetrix closes oversubscribed Series A financing round

Scientists receive €85 million international drive to develop new and effective drugs

PAREXEL launches marketing initiative to simplify journey from science to new treatments

DCR enters into agreement with Pyxant Labs for early clinical trials

ADM commits $25 million equity investment in Rennovia

QuadraMed strikes strategic partnership with Connected Technology Solutions

Theorem Clinical Research forms strategic alliance with Decision Driver Analytics

Ligand Pharmaceuticals' total revenues for Q4 2013 increase 8% to $14.7 million

Zoetis reports revenue of $1.25 billion for Q4 2013

Mallinckrodt's subsidiary to acquire all outstanding shares of Cadence Pharmaceuticals

Cambrex fourth quarter sales increase 46.3% to $103 million

Cardiome Pharma's subsidiary signs agreement with Tamro to distribute BRINAVESS in Sweden

Henry Schein net sales increase 4.9% to $2.5 billion in fourth quarter 2013

UPS completes acquisition of U.K.-based Polar Speed

GenomOncology collaborates with RPCI to develop informatics solution for Next Generation Sequencing

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Latest News